The treatment of chronic lymphocytic leukemia with COP chemotherapy
- 1 May 1978
- Vol. 41 (5), 1664-1669
- https://doi.org/10.1002/1097-0142(197805)41:5<1664::aid-cncr2820410503>3.0.co;2-q
Abstract
Since single drug therapy of chronic lymphocytic leukemia (CLL) has not resulted in prolonged remissions of advanced disease, we initiated a program of combination chemotherapy, COP (cycloposphamide, vincristine sulfate, prednisone) for CLL patients with increasing adenopathy, splenomegaly, and/or signs of marrow failure defined as either anemia or thrombocytopenia. Thirty-six patients received COP either as initial therapy or following progression of disease on single agent therapy. The response rate was 72% with 26 patients responding (16 complete remissions, and 10 good partial remissions). The responses lasted from 8 to 50+ months. Sixteen of the responding patients remain in remission, 2 have active disease and 8 have died. Median survival has not yet been reached but the two-year survival from initiation of COP of the responding patients (complete and good partial response) is 90%. Ten patients had either poor partial or no response with median survival of 18 months. The median survival of the entire group of 36 patients is 35 months. COP is an effective and well tolerated therapy for advanced chronic lymphocytic leukemia.This publication has 19 references indexed in Scilit:
- Malignant lymphoma, well differentiated lymphocytic.Its relationship with chronic lymphocytic leukemia and macroglobulinemia of WaldenströmCancer, 1977
- Total body irradiation of chronic lymphocytic leukemia.Relationship between therapeutic response and prognosisCancer, 1976
- Lymphosarcoma. A comparison of extended to conservative chemotherapyCancer, 1976
- Morphology of chronic lymphocytic leukemia and its relationship to survivalAmerican Journal Of Medicine, 1975
- Bone marrow and peripheral blood lym-phocytosis in the prognosis of chronic lymphocytic leukemiaCancer, 1974
- Bi-weekly chlorambucil treatment of chronic lymphocytic leukemiaCancer, 1974
- Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemiaCancer, 1973
- Chronic myelocytic and chronic lymphocytic leukemiaCancer, 1972
- Vincristine therapy of lymphomas and chronic lymphocytic leukemiaCancer, 1970
- Factors influencing the duration of survival of patients with chronic lymphocytic leukemiaAmerican Journal Of Medicine, 1966